The USPTO has processed a renewal for the trademark VETONE PROPOVAN CF (TM87135826), originally filed on August 11, 2016. This renewal extends the trademark's protection for veterinary preparations used as anesthetics for animals, specifically propofol injection. The renewal is effective March 22, 2026.

This action signifies the continued legal protection for this specific veterinary pharmaceutical product. While this is a routine trademark renewal and does not impose new regulatory obligations, it confirms the owner's exclusive rights to use the mark in commerce for the specified goods. Compliance officers in the pharmaceutical sector should note this renewal as it pertains to a product in their market.